270 related articles for article (PubMed ID: 18401435)
21. The oncolytic effects of reovirus in canine solid tumor cell lines.
Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
[TBL] [Abstract][Full Text] [Related]
22. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
[TBL] [Abstract][Full Text] [Related]
23. Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis.
Gebremeskel S; Nelson A; Walker B; Oliphant T; Lobert L; Mahoney D; Johnston B
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33722907
[TBL] [Abstract][Full Text] [Related]
24. Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
Twigger K; Roulstone V; Kyula J; Karapanagiotou EM; Syrigos KN; Morgan R; White C; Bhide S; Nuovo G; Coffey M; Thompson B; Jebar A; Errington F; Melcher AA; Vile RG; Pandha HS; Harrington KJ
BMC Cancer; 2012 Aug; 12():368. PubMed ID: 22920673
[TBL] [Abstract][Full Text] [Related]
25. Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
Zhao X; Chester C; Rajasekaran N; He Z; Kohrt HE
Mol Cancer Ther; 2016 May; 15(5):767-73. PubMed ID: 27197256
[TBL] [Abstract][Full Text] [Related]
26. Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy.
Ilett E; Kottke T; Thompson J; Rajani K; Zaidi S; Evgin L; Coffey M; Ralph C; Diaz R; Pandha H; Harrington K; Selby P; Bram R; Melcher A; Vile R
Gene Ther; 2017 Jan; 24(1):21-30. PubMed ID: 27779616
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan.
Maitra R; Seetharam R; Tesfa L; Augustine TA; Klampfer L; Coffey MC; Mariadason JM; Goel S
Oncotarget; 2014 May; 5(9):2807-19. PubMed ID: 24798549
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of oncolytic reovirus against human breast cancer cells.
Hata Y; Etoh T; Inomata M; Shiraishi N; Nishizono A; Kitano S
Oncol Rep; 2008 Jun; 19(6):1395-8. PubMed ID: 18497942
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells.
Adair RA; Scott KJ; Fraser S; Errington-Mais F; Pandha H; Coffey M; Selby P; Cook GP; Vile R; Harrington KJ; Toogood G; Melcher AA
Int J Cancer; 2013 May; 132(10):2327-38. PubMed ID: 23114986
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic reovirus in canine mast cell tumor.
Hwang CC; Umeki S; Kubo M; Hayashi T; Shimoda H; Mochizuki M; Maeda K; Baba K; Hiraoka H; Coffey M; Okuda M; Mizuno T
PLoS One; 2013; 8(9):e73555. PubMed ID: 24073198
[TBL] [Abstract][Full Text] [Related]
31. Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models.
Campion CA; Soden D; Forde PF
BMC Cancer; 2016 Jul; 16():462. PubMed ID: 27412241
[TBL] [Abstract][Full Text] [Related]
32. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M; Marcato P; Lee PW
Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
[TBL] [Abstract][Full Text] [Related]
33. Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts.
Kurisu N; Kaminade T; Eguchi M; Ishigami I; Mizuguchi H; Sakurai F
Int J Pharm; 2021 Dec; 610():121269. PubMed ID: 34748806
[TBL] [Abstract][Full Text] [Related]
34. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
Mohamed A; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
[TBL] [Abstract][Full Text] [Related]
36. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Reoviral Cytolysis (I): Combination Therapeutics.
Mori Y; Nishikawa SG; Fratiloiu AR; Tsutsui M; Kataoka H; Joh T; Johnston RN
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515160
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma.
Pandha HS; Heinemann L; Simpson GR; Melcher A; Prestwich R; Errington F; Coffey M; Harrington KJ; Morgan R
Clin Cancer Res; 2009 Oct; 15(19):6158-66. PubMed ID: 19773377
[TBL] [Abstract][Full Text] [Related]
39. Anticancer efficiency of reovirus in normoxia and hypoxia.
Figová K; Hraběta J; Eckschlager T
Folia Biol (Praha); 2013; 59(2):68-75. PubMed ID: 23746172
[TBL] [Abstract][Full Text] [Related]
40. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
Mohamed A; Johnston RN; Shmulevitz M
Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]